Edition:
United Kingdom

Ypsomed Holding AG (YPSN.S)

YPSN.S on Swiss Exchange

171.90CHF
4:29pm GMT
Change (% chg)

CHF0.60 (+0.35%)
Prev Close
CHF171.30
Open
CHF172.30
Day's High
CHF173.00
Day's Low
CHF170.60
Volume
16,312
Avg. Vol
20,199
52-wk High
CHF228.70
52-wk Low
CHF132.50

Latest Key Developments (Source: Significant Developments)

Ypsomed increases its forecast to an operating result of CHF 60 mln
Thursday, 9 Nov 2017 

Nov 9(Reuters) - YPSOMED HOLDING AG ::SAYS FIRST SIX MONTHS OF 2017/18, A CONSOLIDATED TOTAL TURNOVER OF CHF 213.4 MILLION. THE GROWTH CORRESPONDS TO AN INCREASE IN TURNOVER OF 15.1 PCT (PREVIOUS YEAR: CHF 185.4 MILLION).SAYS THE NET PROFIT FOR THE REPORTING PERIOD AMOUNTS TO CHF 23.4 MILLION (PREVIOUS YEAR CHF 22.4 MILLION).SAYS OPERATING RESULT AMOUNTS TO CHF 26.9 MILLION WITH AN EBIT MARGIN OF 12.9  PCT.SAYS EXPECTS A GROWTH IN TURNOVER OF APPROXIMATELY 18 PCT VERSUS THE PRESENTLY FORECAST 15 PCT AND INCREASES THE FORECAST TO AN OPERATING RESULT OF AROUND CHF 60 MILLION FOR THE BUSINESS YEAR 2017/18.  Full Article

Ypsomed and US Bigfoot Biomedical company announce partnership
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - YPSOMED HOLDING AG ::‍YPSOMED AND US BIGFOOT BIOMEDICAL COMPANY TODAY ANNOUNCED THEIR AGREEMENT FOR A PARTNERSHIP​.‍YPSOMED WILL SUPPLY BIGFOOT BIOMEDICAL WITH A MODIFIED, PATENTED VERSION OF ORBIT INFUSION SET​.  Full Article

Ypsomed Holding sets up three new subsidiaries
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - YPSOMED HOLDING AG ::OPENS UP NEW MARKETS‍​.YPSOMED HAS SET UP THREE FURTHER SUBSIDIARIES DURING THE PAST WEEKS, IN BELGIUM, SPAIN AND POLAND.  Full Article

Ypsomed Holding FY net profit up at 35.8 mln Swiss francs
Friday, 20 May 2016 

Ypsomed Holding AG : FY consolidated sales totaling 336.9 million Swiss francs ($339.82 million) (prior year: 306.6 million Swiss francs) . FY EBIT also increased by 55.7 pct compared to the previous year, from 28.5 million Swiss francs to 44.4 million Swiss francs . For the current business year 2016/17, Ypsomed expects an accelerated growth in sales of around 12 pct and an EBIT of approx. 55 million Swiss francs . Shareholders shall be paid a dividend of 1.00 Swiss francs per registered share .FY net profit for the business year 2015/16 amounts to a total of 35.8 million Swiss francs, compared to the previous year at 19.4 million Swiss francs.  Full Article

BRIEF-Ypsomed increases its forecast to an operating result of CHF 60 mln

* SAYS FIRST SIX MONTHS OF 2017/18, A CONSOLIDATED TOTAL TURNOVER OF CHF 213.4 MILLION. THE GROWTH CORRESPONDS TO AN INCREASE IN TURNOVER OF 15.1 PCT (PREVIOUS YEAR: CHF 185.4 MILLION)